EPR26-165: Risk Factors for Infection in Chronic Lymphocytic Leukemia: Insights From a Real-World Cohort Treated With Bruton Tyrosine Kinase Inhibitors or Venetoclax

View at publisher Summarise with VIRAT
Authors: Divya Samat, Shivam Singh
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Neutropenia and Cancer Infections

Publication details

Journal / source
Journal of the National Comprehensive Cancer Network
Volume
24
Issue
3.5
Publication date
27 March 2026
Language
EN